Literature DB >> 11146726

Histopathological features of ocular toxoplasmosis in the fetus and infant.

F Roberts1, M B Mets, D J Ferguson, R O'Grady, C O'Grady, P Thulliez, A P Brézin, R McLeod.   

Abstract

BACKGROUND: Ocular disease is a frequent manifestation of congenital Toxoplasma gondii infection. There are only limited data available in the literature concerning early stages of this disease in fetuses and infants. The purpose of our study was to characterize histopathological features in the eyes of 10 fetuses and 2 infants with congenital toxoplasmosis.
METHODS: Fifteen eyes from 10 fetuses, 3 eyes from 2 premature infants, and both eyes from a 2-year-old child with congenital toxoplasmosis were examined by light microscopy. Immunohistochemical analysis to identify inflammatory cells and T gondii antigens was performed. The findings in infected eyes were compared with those of age-matched control eyes.
RESULTS: Retinitis (10/18 eyes), retinal necrosis (4/18 eyes), disruption of the retinal pigment epithelium (12/18 eyes), and choroidal inflammation and congestion (15/18 eyes) were characteristic findings. Optic neuritis was present in 5 of 8 fetal eyes with associated optic nerve available for evaluation. An eye obtained from a 32-week-old fetus showed retinal rosettes at the edge of a scar. T cells predominated in retinal lesions and choroid. Parasites were identified by immunohistochemical analysis in 10 of 18 eyes.
CONCLUSIONS: Ocular toxoplasmosis causes irreversible damage to the retina in utero. The fetus and infant mount inflammatory responses that may contribute to ocular damage. These findings have important implications for serological screening programs and in utero therapy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11146726

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  20 in total

1.  The effect of toxoplasmosis on the level of some sex hormones in males blood donors in Baghdad.

Authors:  Khawla Hori Zghair; Ban Nori Al-Qadhi; Suhad Hasan Mahmood
Journal:  J Parasit Dis       Date:  2013-11-21

2.  Newborn screening for congenital toxoplasmosis: feasible, but benefits are not established.

Authors:  R Gilbert; C Dezateux
Journal:  Arch Dis Child       Date:  2006-08       Impact factor: 3.791

3.  Genetic Polymorphisms in Cytokine Genes in Colombian Patients with Ocular Toxoplasmosis.

Authors:  C A Naranjo-Galvis; A de-la-Torre; L E Mantilla-Muriel; L Beltrán-Angarita; X Elcoroaristizabal-Martín; R McLeod; N Alliey-Rodriguez; I J Begeman; C López de Mesa; J E Gómez-Marín; J C Sepúlveda-Arias
Journal:  Infect Immun       Date:  2018-03-22       Impact factor: 3.441

4.  Rapid discovery of inhibitors of Toxoplasma gondii using hybrid structure-based computational approach.

Authors:  Sandhya Kortagere; Ernest Mui; Rima McLeod; William J Welsh
Journal:  J Comput Aided Mol Des       Date:  2011-02-26       Impact factor: 3.686

5.  Repurposing the open access malaria box to discover potent inhibitors of Toxoplasma gondii and Entamoeba histolytica.

Authors:  Fabrice F Boyom; Patrick V T Fokou; Lauve R Y Tchokouaha; Thomas Spangenberg; Alvine N Mfopa; Ruffin M T Kouipou; Cedric J Mbouna; Valerie F Donkeng Donfack; Paul H A Zollo
Journal:  Antimicrob Agents Chemother       Date:  2014-07-21       Impact factor: 5.191

Review 6.  Ocular toxoplasmosis II: clinical features, pathology and management.

Authors:  Nicholas J Butler; João M Furtado; Kevin L Winthrop; Justine R Smith
Journal:  Clin Exp Ophthalmol       Date:  2012-09-17       Impact factor: 4.207

7.  Evidence for associations between the purinergic receptor P2X(7) (P2RX7) and toxoplasmosis.

Authors:  S E Jamieson; A L Peixoto-Rangel; A C Hargrave; L-A de Roubaix; E J Mui; N R Boulter; E N Miller; S J Fuller; J S Wiley; L Castellucci; K Boyer; R G Peixe; M J Kirisits; L de Souza Elias; J J Coyne; R Correa-Oliveira; M Sautter; N C Smith; M P Lees; C N Swisher; P Heydemann; A G Noble; D Patel; D Bardo; D Burrowes; D McLone; N Roizen; S Withers; L M G Bahia-Oliveira; R McLeod; J M Blackwell
Journal:  Genes Immun       Date:  2010-06-10       Impact factor: 2.676

Review 8.  Obstetrician-gynecologists and perinatal infections: a review of studies of the Collaborative Ambulatory Research Network (2005-2009).

Authors:  Meaghan A Leddy; Bernard Gonik; Jay Schulkin
Journal:  Infect Dis Obstet Gynecol       Date:  2010-11-11

9.  Modification of triclosan scaffold in search of improved inhibitors for enoyl-acyl carrier protein (ACP) reductase in Toxoplasma gondii.

Authors:  Jozef Stec; Alina Fomovska; Gustavo A Afanador; Stephen P Muench; Ying Zhou; Bo-Shiun Lai; Kamal El Bissati; Mark R Hickman; Patty J Lee; Susan E Leed; Jennifer M Auschwitz; Caroline Sommervile; Stuart Woods; Craig W Roberts; David Rice; Sean T Prigge; Rima McLeod; Alan P Kozikowski
Journal:  ChemMedChem       Date:  2013-06-14       Impact factor: 3.466

Review 10.  Why prevent, diagnose and treat congenital toxoplasmosis?

Authors:  Rima McLeod; Francois Kieffer; Mari Sautter; Tiffany Hosten; Herve Pelloux
Journal:  Mem Inst Oswaldo Cruz       Date:  2009-03       Impact factor: 2.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.